Literature DB >> 1493588

Regulation of intestinal glucose transport.

D J Philpott1, J D Butzner, J B Meddings.   

Abstract

The small intestine is capable of adapting nutrient transport in response to numerous stimuli. This review examines several possible mechanisms involved in intestinal adaptation. In some cases, the enhancement of transport is nonspecific, that is, the absorption of many nutrients is affected. Usually, increased transport capacity in these instances can be attributed to an increase in intestinal surface area. Alternatively, some conditions induce specific regulation at the level of the enterocyte that affects the transport of a particular nutrient. Since the absorption of glucose from the intestine is so well characterized, it serves as a useful model for this type of intestinal adaptation. Four potential sites for the specific regulation of glucose transport have been described, and each is implicated in different situations. First, mechanisms at the brush-border membrane of the enterocyte are believed to be involved in the upregulation of glucose transport that occurs in streptozotocin-induced diabetes mellitus and alterations in dietary carbohydrate levels. Also, factors that increase the sodium gradient across the enterocyte may increase the rate of glucose transport. It has been suggested that an increase in activity of the basolaterally located Na(+)-K+ ATPase could be responsible for this phenomena. The rapid increase in glucose uptake seen in hyperglycemia seems to be mediated by an increase in both the number and activity of glucose carriers located at the basolateral membrane. More recently, it was demonstrated that mechanisms at the basolateral membrane also play a role in the chronic increase in glucose transport observed when dietary carbohydrate levels are increased. Finally, alterations in tight-junction permeability enhance glucose absorption from the small intestine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493588     DOI: 10.1139/y92-167

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  Ouabain binding to Na+,K+-ATPase relaxes cell attachment and sends a specific signal (NACos) to the nucleus.

Authors:  R G Contreras; C Flores-Maldonado; A Lázaro; L Shoshani; D Flores-Benitez; I Larré; M Cereijido
Journal:  J Membr Biol       Date:  2004-04-01       Impact factor: 1.843

2.  Inhibitory effect of luminal saccharides on glucose absorption from an adjacent jejunal site in rats: a newly described intestinal neural reflex.

Authors:  Fadi H Mourad; Kassem A Barada; Nayef E Saade
Journal:  Pflugers Arch       Date:  2018-11-06       Impact factor: 3.657

3.  Absorption of D-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach.

Authors:  Y Wang; R Aun; F L Tse
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

4.  Acute increase, stimulated by prostaglandin E2, in glucose absorption via the sodium dependent glucose transporter-1 in rat intestine.

Authors:  B Scholtka; F Stümpel; K Jungermann
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

5.  Effect of oral administration of a single bolus of six different protein sources on digestive physiology of red seabream Pagrus major juveniles.

Authors:  Koji Murashita; Fumiaki Takakuwa; Hiroyuki Matsunari; Hazuki Yoshinaga; Takeshi Yamamoto; Hiromi Oku; Hirofumi Furuita
Journal:  Fish Physiol Biochem       Date:  2022-06-29       Impact factor: 3.014

6.  Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes.

Authors:  C F Burant; S Flink; A M DePaoli; J Chen; W S Lee; M A Hediger; J B Buse; E B Chang
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

7.  Glucose absorption and gastric emptying in critical illness.

Authors:  Marianne J Chapman; Robert J L Fraser; Geoffrey Matthews; Antonietta Russo; Max Bellon; Laura K Besanko; Karen L Jones; Ross Butler; Barry Chatterton; Michael Horowitz
Journal:  Crit Care       Date:  2009-08-27       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.